Leprosy Mailing List – August 8, 2023
Ref.: (LML) Fixed duration multidrug therapy (12 months) in leprosy patients with high bacillary load – Need to look beyond
From: Sinésio Talhari, Manaus, Brazil
Dear colleagues,
I fully agree with Dr. Sandra Duraes (LML, August 3, 2023) and, mainly with what was highlighted in relation to the article in question: "the U-MDT study from Brazil showed seven times more relapses in the 6-month regimen (U-MDT) compared to 12 months of treatment (FD-MDT )". I also ask the authors to explain how they arrived at this conclusion based on the results and methodological and statistical analyzes of the research. I participated in this study and this recurrence rate is not included in the published articles.
Yours sincerely,
Prof. Dr. Sinésio Talhari
Fundaçao de Dermatologia Tropical e Venereologia "Alfredo da Matt
Manaus, Amazonas, Brasil
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
--You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/0b9ce050-5438-4171-9dc6-135d16eadf5en%40googlegroups.com.
No comments:
Post a Comment